JEŠETA, Michal, Jana NAVRÁTILOVÁ, Kateřina FRANZOVÁ, Sandra FIALKOVÁ, Bartozs KEMPISTY, Pavel VENTRUBA, Jana ŽÁKOVÁ and Igor CRHA. Overview of the Mechanisms of Action of Selected Bisphenols and Perfluoroalkyl Chemicals on the Male Reproductive Axes. Frontiers in Genetics. Laussane: FRONTIERS MEDIA SA, 2021, vol. 12, September 2021, p. 1-13. ISSN 1664-8021. Available from: https://dx.doi.org/10.3389/fgene.2021.692897.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Overview of the Mechanisms of Action of Selected Bisphenols and Perfluoroalkyl Chemicals on the Male Reproductive Axes
Authors JEŠETA, Michal (203 Czech Republic, guarantor, belonging to the institution), Jana NAVRÁTILOVÁ (203 Czech Republic, belonging to the institution), Kateřina FRANZOVÁ (203 Czech Republic, belonging to the institution), Sandra FIALKOVÁ (703 Slovakia, belonging to the institution), Bartozs KEMPISTY (616 Poland), Pavel VENTRUBA (203 Czech Republic, belonging to the institution), Jana ŽÁKOVÁ (203 Czech Republic, belonging to the institution) and Igor CRHA (203 Czech Republic, belonging to the institution).
Edition Frontiers in Genetics, Laussane, FRONTIERS MEDIA SA, 2021, 1664-8021.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10603 Genetics and heredity
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.772
RIV identification code RIV/00216224:14110/21:00120172
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3389/fgene.2021.692897
UT WoS 000717298400001
Keywords in English male infertility; spermatogenesis; steroidogenesis; endocrine disrupting chemicals; bisphenol; spermatozoa; perfluoroalkyl substances
Tags 14110411, 14110611, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 4/3/2022 13:24.
Abstract
Male fertility has been deteriorating worldwide for considerable time, with the greatest deterioration recorded mainly in the United States, Europe countries, and Australia. That is, especially in countries where an abundance of chemicals called endocrine disruptors has repeatedly been reported, both in the environment and in human matrices. Human exposure to persistent and non-persistent chemicals is ubiquitous and associated with endocrine-disrupting effects. This group of endocrine disrupting chemicals (EDC) can act as agonists or antagonists of hormone receptors and can thus significantly affect a number of physiological processes. It can even negatively affect human reproduction with an impact on the development of gonads and gametogenesis, fertilization, and the subsequent development of embryos. The negative effects of endocrine disruptors on sperm gametogenesis and male fertility in general have been investigated and repeatedly demonstrated in experimental and epidemiological studies. Male reproduction is affected by endocrine disruptors via their effect on testicular development, impact on estrogen and androgen receptors, potential epigenetic effect, production of reactive oxygen species or direct effect on spermatozoa and other cells of testicular tissue. Emerging scientific evidence suggests that the increasing incidence of male infertility is associated with the exposure to persistent and non-persistent endocrine-disrupting chemicals such as bisphenols and perfluoroalkyl chemicals (PFAS). These chemicals may impact men's fertility through various mechanisms. This study provides an overview of the mechanisms of action common to persistent (PFAS) and nonpersistent (bisphenols) EDC on male fertility.

Links
EF17_043/0009632, research and development projectName: CETOCOEN Excellence
EF19_074/0012727, research and development projectName: MSCAfellow3@MUNI
LM2018121, research and development projectName: Výzkumná infrastruktura RECETOX (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR, RECETOX RI
NV18-08-00412, research and development projectName: Lidské embryonální kmenové buňky pro klinické aplikace: derivace a charakterizace
Investor: Ministry of Health of the CR
PrintDisplayed: 22/7/2024 16:15